Linezolid and Diffuse alveolar damage - a phase IV clinical study of FDA data

Summary:

Diffuse alveolar damage is reported as a side effect among people who take Linezolid (linezolid), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lovenox, and have Skin infection.

The phase IV clinical study analyzes which people have Diffuse alveolar damage when taking Linezolid. It is created by eHealthMe based on reports of 21,827 people who have side effects when taking Linezolid from the FDA, and is updated regularly.

What is Linezolid?

Linezolid has active ingredients of linezolid. It is often used in infection. eHealthMe is studying from 21,891 Linezolid users. Check the latest studies of Linezolid.

What is Diffuse alveolar damage?

Diffuse alveolar damage (common manifestation of drug-induced lung injury) is found to be associated with 145 drugs and 361 conditions by eHealthMe. Check the latest studies of Diffuse alveolar damage.

On Jul, 29, 2026

21,827 people reported to have side effects when taking Linezolid.
Among them, 51 people (0.23%) have Diffuse alveolar damage.

Could Linezolid cause Diffuse alveolar damage?

Among these 51 people:

How long have people been on Linezolid when they have Diffuse alveolar damage? *

What is the gender of people who have Diffuse alveolar damage when taking Linezolid? *

female: 2.04 %
male: 97.96 %

What is the age of people who have Diffuse alveolar damage when taking Linezolid? *

What are other drugs people take besides Linezolid? *

Lovenox: 47 people, 92.16%
Lantus: 46 people, 90.20%
Polaramine: 46 people, 90.20%
Pantoprazole: 43 people, 84.31%
Ultravist: 42 people, 82.35%
Questran: 42 people, 82.35%
Cubicin: 42 people, 82.35%
Rifadin: 39 people, 76.47%
Duphalac: 37 people, 72.55%
Piperacillin And Tazobactam: 26 people, 50.98%

What are other side effects people have besides Diffuse alveolar damage? *

Dyspnea (difficult or laboured breathing): 49 people, 96.08%
Sepsis (a severe blood infection that can lead to organ failure and death): 49 people, 96.08%
Generalised Oedema (swelling all over the body): 49 people, 96.08%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 48 people, 94.12%
Eosinophilia (eosinophil count in the peripheral blood exceeds): 48 people, 94.12%
Eosinophilic Pneumonia (eosinophil accumulates in the lung): 48 people, 94.12%
Glomerular Filtration Rate Decreased: 48 people, 94.12%
Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 48 people, 94.12%
Hyperammonaemia: 48 people, 94.12%
Thrombocytopenia (decrease of platelets in blood): 48 people, 94.12%

What are the existing conditions these people have? *

Skin Infection: 48 people, 94.12%
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 1 person, 1.96%
Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 1.96%
Pneumonia Bacterial (pneumonia associated with bacterial infection): 1 person, 1.96%
Pneumonia: 1 person, 1.96%
H1n1 Influenza (flu (influenza), which is caused by virus influenza a (h1n1)): 1 person, 1.96%
Cytomegalovirus Test Positive: 1 person, 1.96%
Aplastic Anemia: 1 person, 1.96%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 1.96%

* Approximation only. Some reports may have incomplete information.

Do you take Linezolid and have Diffuse alveolar damage?

- Check whether Diffuse alveolar damage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Linezolid:

Linezolid (21,891 reports)

Browse all side effects of Linezolid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diffuse alveolar damage:

Diffuse alveolar damage (145 drugs)

Browse all the conditions that are associated with Diffuse alveolar damage:

Diffuse alveolar damage (361 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on linezolid (the active ingredients of Linezolid) and Linezolid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.